Taro Pharmaceutical
TARO
#4731
Rank
A$2.48 B
Marketcap
$65.99
Share price
0.00%
Change (1 day)
9.33%
Change (1 year)

Revenue for Taro Pharmaceutical (TARO)

Revenue in 2023 (TTM): A$0.91 Billion

According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM ) is A$0.93 Billion. an increase over the revenue in the year 2022 that were of A$0.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taro Pharmaceutical from 1996 to 2023

Annual revenue

Year Revenue Change
2023 A$0.89 B7.11%
2022 A$0.83 B7.14%
2021 A$0.78 B4.38%
2020 A$0.74 B-19.34%
2019 A$0.92 B-1.72%
2018 A$0.94 B7.91%
2017 A$0.87 B-33.47%
2016 A$1.31 B3.04%
2015 A$1.27 B29.61%
2014 A$0.98 B19.15%
2013 A$0.82 B31.95%
2012 A$0.62 B27.02%
2011 A$0.49 B27.82%
2010 A$0.38 B-3.09%
2009 A$0.39 B
2005 A$0.41 B12.45%
2004 A$0.36 B-13.49%
2003 A$0.42 B13.01%
2002 A$0.37 B27.66%
2001 A$0.29 B58.46%
2000 A$0.18 B45.6%
1999 A$0.12 B17.05%
1998 A$0.10 B16.15%
1997 A$93.78 M31.86%
1996 A$71.12 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$85.44 B 9,009.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$95.94 B 10,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$134.67 B 14,256.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.01 B 2,566.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$61.81 B 6,489.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$76.69 B 8,075.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland